As of Nov 19, 2026, 0 of 1 active firms rate TVGN a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
TVGN EPS & revenue forecast
EPS · NEXT QUARTER
$-2.50
Range $-2.50 – $-2.50 · 1 analysts · +67% YoY
Next period, 1 analysts expect Tevogen Bio Holdings Inc. to earn $-2.50 a share (range $-2.50 – $-2.50), versus $-1.50 a year earlier. , growing to $-13.00 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 1 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Tevogen Bio Holdings Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TVGN.
#1
Jason Kolbert
D. Boral Capital · Rank #562
Neutral
No targeton TVGN
Overall win rate
22%
+ Follow
TVGN stock forecast FAQ
What is TVGN's average 12-month price target?+
The 1 active firms with a live target average $2.00 for Tevogen Bio Holdings Inc. over the next 12 months, ranging from a $2.00 high to a $2.00 low, as of Nov 19, 2026.
Is TVGN stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover TVGN?+
1 active firms have a recognized rating on Tevogen Bio Holdings Inc. as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering TVGN?+
Among analysts who currently cover TVGN, Jason Kolbert of D. Boral Capital has the strongest overall Quantellect track record (Rank #562). Their current call is Neutral.
What is Tevogen Bio Holdings Inc.'s projected EPS for next quarter?+
The consensus estimate is $-2.50 per share (range $-2.50 – $-2.50) across 1 analysts. Full-year EPS is projected at —, rising to $-13.00 the following year.
How much revenue is Tevogen Bio Holdings Inc. expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading TVGN lately?+
As of Nov 19, 2026, 0 of 1 active firms rate TVGN a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TVGN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.